Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment

被引:31
作者
Josefsson, A
Wikström, P
Granfors, T
Egevad, L
Karlberg, L
Stattin, P
Bergh, A
机构
[1] Umea Univ, Dept Surg & Perioperat Sci, SE-90185 Umea, Sweden
[2] Cent Hosp Vasteras, Dept Urol, Vasteras, Sweden
[3] Karolinska Univ Hosp, Dept Pathol & Cytol, Solna, Stockholm, Sweden
关键词
von Willebrand factor; endoglin; Ki67; immunohistochemistry; survival analysis; prostate cancer;
D O I
10.1016/j.eururo.2005.05.016
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To investigate the prognostic value of potential markers in localized, Gleason score 6 and 7 prostate cancer (PC). Methods: From a consecutive series of men with PC diagnosed at transurethral resection (1975-1990),. specimens from 132 patients without metastases, with Gleason score (GS) 6 (n = 80) or 7 (n = 52) tumors followed with watchful waiting were examined. The fraction of resected prostate tissue containing cancer, the micro-vessel density (v.d.) when stained for endoglin or von Willebrand factor (vWf), and the percentage of Ki-67 labeled tumor cells were measured using immunohistochemistry. Results: High levels of vWf v.d., endoglin v.d., and percent cancer of the TURP specimen were significantly associated with short cancer-specific survival in Kaplan-Meier analysis of all patients with GS 6 and 7 tumors. Interestingly, a combined estimate of percent cancer and vWF v.d. could be used to identify a large subset (50%) of GS 6 tumors with only a 2.5% risk of PC death within 15 years. None of the tested markers gave independent prognostic information for the GS 7 tumors. Conclusions: Estimates of tumor size and vascular density may identify a large proportion of non-aggressive GS 6, but not GS 7, tumors. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:577 / 583
页数:7
相关论文
共 22 条
[1]  
Ayala G, 2003, CANCER RES, V63, P6244
[2]   Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting [J].
Borre, M ;
Offersen, BV ;
Nerstrom, B ;
Overgaard, J .
BRITISH JOURNAL OF CANCER, 1998, 78 (07) :940-944
[3]   Evaluating prostate needle biopsy: Therapeutic and prognostic importance [J].
Bostwick, DG .
CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (05) :297-&
[4]  
Cheng L, 1999, CANCER, V85, P1300, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1300::AID-CNCR12>3.0.CO
[5]  
2-#
[6]   Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection [J].
Egevad, L ;
Granfors, T ;
Karlberg, L ;
Bergh, A ;
Stattin, P .
JOURNAL OF UROLOGY, 2002, 168 (02) :509-513
[7]   Prognostic value of the Gleason score in prostate cancer [J].
Egevad, L ;
Granfors, T ;
Karlberg, L ;
Bergh, A ;
Stattin, P .
BJU INTERNATIONAL, 2002, 89 (06) :538-542
[8]   Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score [J].
Freedland, SJ ;
Csathy, GS ;
Dorey, F ;
Aronson, WJ .
JOURNAL OF UROLOGY, 2002, 167 (02) :516-520
[9]   Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer [J].
Graefen, M ;
Ohori, M ;
Karakiewicz, PI ;
Cagiannos, I ;
Hammerer, PG ;
Haese, A ;
Erbersdobler, A ;
Henke, RP ;
Huland, H ;
Wheeler, TM ;
Slawin, K ;
Scardino, PT ;
Kattan, MW .
JOURNAL OF UROLOGY, 2004, 171 (01) :200-203
[10]   Primary gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer - A multivariate analysis of 823 men treated with radical prostatectomy [J].
Herman, CM ;
Kattan, MW ;
Ohori, M ;
Scardino, PT ;
Wheeler, TM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (05) :657-660